These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 37516572

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Early Evidence of the Effectiveness of the Human Papillomavirus Vaccination Program Against Anogenital Warts in Manitoba, Canada: A Registry Cohort Study.
    Willows K, Bozat-Emre S, Righolt CH, Kliewer EV, Mahmud SM.
    Sex Transm Dis; 2018 Apr; 45(4):254-259. PubMed ID: 29465699
    [Abstract] [Full Text] [Related]

  • 5. Declines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017.
    Checchi M, Mesher D, Mohammed H, Soldan K.
    Sex Transm Infect; 2019 Aug; 95(5):368-373. PubMed ID: 30723186
    [Abstract] [Full Text] [Related]

  • 6. Impact of a single-age cohort human papillomavirus vaccination strategy in Catalonia, Spain: Population-based analysis of anogenital warts in men and women.
    Brotons M, Monfil L, Roura E, Duarte-Salles T, Casabona J, Urbiztondo L, Cabezas C, Bosch FX, de Sanjosé S, Bruni L.
    Prev Med; 2020 Sep; 138():106166. PubMed ID: 32565118
    [Abstract] [Full Text] [Related]

  • 7. Early impact of Ontario's human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment.
    Guerra FM, Rosella LC, Dunn S, Wilson SE, Chen C, Deeks SL.
    Vaccine; 2016 Sep 07; 34(39):4678-4683. PubMed ID: 27527815
    [Abstract] [Full Text] [Related]

  • 8. The early impact of human papillomavirus vaccination on anogenital warts in Québec, Canada.
    Steben M, Ouhoummane N, Rodier C, Sinyavskaya L, Brassard P.
    J Med Virol; 2018 Mar 07; 90(3):592-598. PubMed ID: 28980715
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A Review of the Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: 10 Years of Clinical Experience in Canada.
    Steben M, Tan Thompson M, Rodier C, Mallette N, Racovitan V, DeAngelis F, Stutz M, Rampakakis E.
    J Obstet Gynaecol Can; 2018 Dec 07; 40(12):1635-1645. PubMed ID: 30341021
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.